Yanagiya, Ryo
Nakagawa, So
Onizuka, Makoto
Kotani, Ai
Funding for this research was provided by:
Tokai University Tokuda Memorial Cancer/Genome Basic Research Grant for Young Investigators
2024 Core Research Fund of the Institute of Medical Sciences at Tokai University
Article History
Received: 7 November 2024
Accepted: 11 March 2025
First Online: 1 April 2025
Declarations
:
: Access to the RNA-seq data used in this study was obtained from the Institutional Review Board of Tokai University School of Medicine (approval number: 19-R-323).
: This manuscript does not contain any identifiable individual person’s data.
: Ryo Yanagiya belongs to a laboratory sponsored by Ohara Pharmaceutical Co. Ltd. from January 2025. The others have no conflict of interest to be disclosed.